• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠后持续性嗅觉障碍的嗅觉训练:阈值的数值正常化而非识别能力的正常化

Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification.

作者信息

Vandersteen Clair, Payne Magali, Dumas Louise-Émilie, Cancian Élisa, Plonka Alexandra, D'Andréa Grégoire, Chirio David, Demonchy Élisa, Risso Karine, Askenazy-Gittard Florence, Savoldelli Charles, Guevara Nicolas, Robert Philippe, Castillo Laurent, Manera Valeria, Gros Auriane

机构信息

Institut Universitaire de la Face et du Cou, Centre Hospitalier Universitaire, Université Côte d'Azur, 31 Avenue de Valombrose, 06100 Nice, France.

Laboratoire CoBTeK, Université Côte d'Azur, 06100 Nice, France.

出版信息

J Clin Med. 2022 Jun 8;11(12):3275. doi: 10.3390/jcm11123275.

DOI:10.3390/jcm11123275
PMID:35743346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9224948/
Abstract

(1) Background: Persistent post-viral olfactory disorders (PPVOD) are estimated at 30% of patients one year after COVID-19 infection. No treatment is, to date, significantly effective on PPVOD with the exception of olfactory training (OT). The main objective of this work was to evaluate OT efficiency on post-COVID-19 PPVOD. (2) Methods: Consecutive patients consulting to the ENT department with post-COVID-19 PPVOD were included after completing clinical examination, the complete Sniffin’ Stick Test (TDI), the short version of the Questionnaire of olfactory disorders and the SF-36. Patients were trained to practice a self-olfactory training with a dedicated olfactory training kit twice a day for 6 months before returning to undergo the same assessments. (3) Results: Forty-three patients were included and performed 3.5 months of OT in average. We observed a significant TDI score improvement, increasing from 24.7 (±8.9) before the OT to 30.9 (±9.8) (p < 0.001). Based on normative data, a significant increase in the number of normosmic participants was observed only for the threshold values (p < 0.001). Specific and general olfaction-related quality of life improved after the OT. (4) Conclusions: Olfactory function appeared to improve only in peripheral aspects of post-COVID-19 PPVOD after OT. Future controlled studies must be performed to confirm the OT role and justify new therapeutic strategies that may focus on the central aspects of post-COVID-19 PPVOD.

摘要

(1)背景:据估计,新冠病毒感染后一年,持续性病毒后嗅觉障碍(PPVOD)在患者中的发生率为30%。迄今为止,除嗅觉训练(OT)外,没有其他治疗方法对PPVOD有显著疗效。这项研究的主要目的是评估OT对新冠病毒感染后PPVOD的疗效。(2)方法:连续的新冠病毒感染后出现PPVOD并到耳鼻喉科就诊的患者,在完成临床检查、完整的嗅觉棒测试(TDI)、嗅觉障碍问卷简版和SF-36后被纳入研究。患者接受训练,使用专门的嗅觉训练套件每天进行两次自我嗅觉训练,持续6个月,之后再次接受相同评估。(3)结果:纳入43例患者,平均进行了3.5个月的OT。我们观察到TDI评分有显著改善,从OT前的24.7(±8.9)提高到30.9(±9.8)(p<0.001)。根据标准数据,仅在阈值方面观察到嗅觉正常参与者的数量有显著增加(p<0.001)。OT后,与嗅觉相关的特定和总体生活质量得到改善。(4)结论:OT后,新冠病毒感染后PPVOD的嗅觉功能似乎仅在周围方面有所改善。未来必须进行对照研究,以证实OT的作用,并为可能侧重于新冠病毒感染后PPVOD中枢方面的新治疗策略提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50d0/9224948/5164acdc8aab/jcm-11-03275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50d0/9224948/34dc18bf92e3/jcm-11-03275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50d0/9224948/5164acdc8aab/jcm-11-03275-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50d0/9224948/34dc18bf92e3/jcm-11-03275-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50d0/9224948/5164acdc8aab/jcm-11-03275-g002.jpg

相似文献

1
Olfactory Training in Post-COVID-19 Persistent Olfactory Disorders: Value Normalization for Threshold but Not Identification.新冠后持续性嗅觉障碍的嗅觉训练:阈值的数值正常化而非识别能力的正常化
J Clin Med. 2022 Jun 8;11(12):3275. doi: 10.3390/jcm11123275.
2
Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics.持续性 COVID-19 嗅觉异常和嗅觉训练后嗅觉丧失:比较中枢和外周作用治疗药物的随机临床试验。
Eur Arch Otorhinolaryngol. 2024 Jul;281(7):3671-3678. doi: 10.1007/s00405-024-08548-6. Epub 2024 Mar 16.
3
Therapeutic options of post-COVID-19 related olfactory dysfunction: a systematic review and meta-analysis.新冠病毒感染后相关嗅觉功能障碍的治疗选择:一项系统综述和荟萃分析
Rhinology. 2023 Feb 1;61(1):2-11. doi: 10.4193/Rhin22.221.
4
Adherence to olfactory training improves orthonasal and retronasal olfaction in post-COVID-19 olfactory loss.坚持嗅觉训练可改善新冠后嗅觉丧失患者的经鼻嗅觉和鼻后嗅觉。
Rhinology. 2024 Dec 1;62(6):681-688. doi: 10.4193/Rhin24.233.
5
A multicenter real-life study to determine the efficacy of corticosteroids and olfactory training in improving persistent COVID-19-related olfactory dysfunction.一项多中心真实世界研究,以确定皮质类固醇和嗅觉训练在改善持续性新冠病毒病相关嗅觉功能障碍方面的疗效。
Laryngoscope Investig Otolaryngol. 2022 Dec 2;8(1):46-54. doi: 10.1002/lio2.989.
6
Olfactory Training Impacts Olfactory Dysfunction Induced by COVID-19: A Pilot Study.嗅觉训练对 COVID-19 引起的嗅觉功能障碍的影响:一项初步研究。
ORL J Otorhinolaryngol Relat Spec. 2023;85(2):57-66. doi: 10.1159/000528188. Epub 2022 Dec 16.
7
SNOT-22 in general population, a Spanish cohort study with an updated meta-analysis.普通人群中的SNOT-22:一项西班牙队列研究及更新的荟萃分析
Rhinology. 2024 Dec 1;62(6):700-709. doi: 10.4193/Rhin24.233.
8
Parosmia COVID-19 Related Treated by a Combination of Olfactory Training and Ultramicronized PEA-LUT: A Prospective Randomized Controlled Trial.嗅觉训练与超微化PEA-LUT联合治疗新冠相关嗅觉障碍:一项前瞻性随机对照试验
Biomedicines. 2023 Apr 6;11(4):1109. doi: 10.3390/biomedicines11041109.
9
What about using sniffin' sticks 12 items test to screen post-COVID-19 olfactory disorders?用嗅棒 12 项测试来筛查新冠后嗅觉障碍如何?
Eur Arch Otorhinolaryngol. 2022 Jul;279(7):3477-3484. doi: 10.1007/s00405-021-07148-y. Epub 2021 Oct 30.
10
Effectiveness of olfactory training in COVID-19 patients with olfactory dysfunction: a prospective study.COVID-19 患者嗅觉障碍嗅觉训练的疗效:一项前瞻性研究。
Eur Arch Otorhinolaryngol. 2023 Mar;280(3):1255-1263. doi: 10.1007/s00405-022-07665-4. Epub 2022 Sep 25.

引用本文的文献

1
Treatments for Olfactory Dysfunction in COVID-19: A Systematic Review.新冠病毒感染嗅觉功能障碍的治疗:一项系统综述
Int Arch Otorhinolaryngol. 2024 May 25;28(4):e728-e743. doi: 10.1055/s-0044-1786046. eCollection 2024 Oct.
2
Maximizing Participation in Olfactory Training in a Sample with Post-COVID-19 Olfactory Loss.在新冠后嗅觉丧失样本中最大化嗅觉训练的参与度
Brain Sci. 2024 Jul 21;14(7):730. doi: 10.3390/brainsci14070730.
3
Recovery rates of persistent post-COVID-19 olfactory dysfunction using psychophysical assessment: A longitudinal cohort study.

本文引用的文献

1
Long-term olfactory dysfunction in COVID-19 patients: 18-month follow-up study.新冠病毒感染患者的长期嗅觉功能障碍:18个月随访研究
Int Forum Allergy Rhinol. 2022 Aug;12(8):1078-1080. doi: 10.1002/alr.22990. Epub 2022 Mar 9.
2
Olfactory training for olfactory dysfunction in COVID-19: A promising mitigation amidst looming neurocognitive sequelae of the pandemic.新冠嗅觉功能障碍的嗅觉训练:大流行神经认知后遗症下的有希望的缓解方法。
Clin Exp Pharmacol Physiol. 2022 Apr;49(4):462-473. doi: 10.1111/1440-1681.13626. Epub 2022 Feb 10.
3
Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up.
使用心理物理学评估的新冠后持续性嗅觉功能障碍的恢复率:一项纵向队列研究。
World J Otorhinolaryngol Head Neck Surg. 2024 May 6;10(2):79-87. doi: 10.1002/wjo2.179. eCollection 2024 Jun.
4
Understanding Patient-Reported Outcome Measures Used in Adult Survivors Experiencing Long-Term Effects After COVID-19 Infection: A Rapid Review.了解新冠病毒感染后出现长期影响的成年幸存者所使用的患者报告结局指标:一项快速综述
J Patient Cent Res Rev. 2024 Apr 2;11(1):36-50. doi: 10.17294/2330-0698.2041. eCollection 2024 Spring.
5
Comparative Analysis of Olfactory and Gustatory Function of Patients With COVID-19 Olfactory Dysfunction and Non-COVID-19 Postinfectious Olfactory Dysfunction.COVID-19 嗅觉功能障碍与非 COVID-19 感染后嗅觉障碍患者嗅觉和味觉功能的比较分析。
J Korean Med Sci. 2023 Nov 6;38(43):e352. doi: 10.3346/jkms.2023.38.e352.
6
Post-viral olfactory loss and parosmia.病毒感染后嗅觉丧失和嗅觉异常。
BMJ Med. 2023 Jul 20;2(1):e000382. doi: 10.1136/bmjmed-2022-000382. eCollection 2023.
7
Subjective Perception of Recovery and Measured Olfactory Function in COVID-19 Patients.新冠患者的嗅觉功能恢复的主观感知与客观测量。
Viruses. 2023 Jun 23;15(7):1418. doi: 10.3390/v15071418.
8
Long COVID, the Brain, Nerves, and Cognitive Function.长期新冠、大脑、神经与认知功能
Neurol Int. 2023 Jul 6;15(3):821-841. doi: 10.3390/neurolint15030052.
9
Clinical effectiveness of rehabilitation in ambulatory care for patients with persisting symptoms after COVID-19: a systematic review.COVID-19 后持续症状患者门诊康复治疗的临床效果:系统评价。
BMC Infect Dis. 2023 Jun 21;23(1):419. doi: 10.1186/s12879-023-08374-x.
10
Persistent post-COVID-19 dysosmia: Practices survey of members of the French National Union of Otorhinolaryngology-Head and Neck Surgery Specialists. CROSS analysis.持续性新冠后嗅觉障碍:法国耳鼻喉头颈外科学会会员实践调查。交叉分析。
Eur Ann Otorhinolaryngol Head Neck Dis. 2023 Aug;140(4):159-163. doi: 10.1016/j.anorl.2023.04.002. Epub 2023 Apr 7.
新冠病毒感染者持续性嗅觉障碍的患病率:一项为期 1 年随访的心理物理学病例对照研究。
Otolaryngol Head Neck Surg. 2022 Jul;167(1):183-186. doi: 10.1177/01945998211061511. Epub 2021 Nov 23.
4
Olfactory recovery following infection with COVID-19: A systematic review.新冠病毒感染后的嗅觉恢复:一项系统评价。
PLoS One. 2021 Nov 9;16(11):e0259321. doi: 10.1371/journal.pone.0259321. eCollection 2021.
5
What about using sniffin' sticks 12 items test to screen post-COVID-19 olfactory disorders?用嗅棒 12 项测试来筛查新冠后嗅觉障碍如何?
Eur Arch Otorhinolaryngol. 2022 Jul;279(7):3477-3484. doi: 10.1007/s00405-021-07148-y. Epub 2021 Oct 30.
6
High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluation.新冠病毒感染后患者长期嗅觉、味觉和化学感觉功能障碍的高发率:一项使用综合心理物理评估的为期一年的配对病例对照研究。
Rhinology. 2021 Dec 1;59(6):517-527. doi: 10.4193/Rhin21.249.
7
Validity and Reliability of the French Short Version of the Questionnaire of Olfactory Disorders-Negative Statements (sQOD-NS).《嗅觉障碍否定陈述问卷(sQOD-NS)的法语短版的有效性和可靠性》。
Ear Nose Throat J. 2024 Feb;103(2):NP113-NP117. doi: 10.1177/01455613211032004. Epub 2021 Aug 31.
8
Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.预防 COVID-19 后持续性嗅觉功能障碍的干预措施。
Cochrane Database Syst Rev. 2021 Jul 22;7(7):CD013877. doi: 10.1002/14651858.CD013877.pub2.
9
Short-Term Efficacy and Safety of Oral and Nasal Corticosteroids in COVID-19 Patients with Olfactory Dysfunction: A European Multicenter Study.口服和鼻用皮质类固醇对新冠病毒嗅觉功能障碍患者的短期疗效和安全性:一项欧洲多中心研究
Pathogens. 2021 Jun 4;10(6):698. doi: 10.3390/pathogens10060698.
10
Comparison of self-reported symptoms and psychophysical tests in coronavirus disease 2019 (COVID-19) subjects experiencing long-term olfactory dysfunction: a 6-month follow-up study.2019年冠状病毒病(COVID-19)长期嗅觉功能障碍患者自我报告症状与心理物理学测试的比较:一项6个月的随访研究。
Int Forum Allergy Rhinol. 2021 Nov;11(11):1592-1595. doi: 10.1002/alr.22828. Epub 2021 Jun 20.